Test Price
2,800 AED✅ Home Collection Available
SLC16A1 Gene Erythrocyte Lactate Transporter Defect Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic accuracy of 99.9% using next‑generation sequencing (NGS) under ISO 9001:2015‑certified protocols.
- VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Post‑test tele‑consultation with a board‑certified consultant medical geneticist for clinical interpretation.
- Direct insurance verification via WhatsApp: +971 54 548 8731.
- Test price: 2,800 AED.
Test Overview & Methodology
The SLC16A1 gene encodes the monocarboxylate transporter 1 (MCT1) critical for lactate shuttling in erythrocytes; pathogenic variants cause a rare metabolic disorder marked by exercise intolerance and lactate accumulation. Our NGS‑based test comprehensively sequences the entire coding region of SLC16A1, delivering a definitive genetic diagnosis with 99.9% analytical sensitivity under ISO 9001:2015‑certified protocols.
| Feature | Our Test (SLC16A1 NGS) | Standard Single‑Gene Sanger Sequencing |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) — covers all exons, splice sites, and regulatory regions | Sanger sequencing — limited to pre‑selected amplicons |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks (often requires multiple runs) |
| Diagnostic Sensitivity | 99.9% analytical sensitivity; concurrent copy number variant detection available | ~85–92% depending on target region coverage |
| Sample Type | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) — flexible | Typically requires whole blood or purified DNA |
| Clinical Support | Post‑test tele‑consultation included | Often report‑only, no clinical interpretation |
Physician Insight & Safety Protocols
“Genetic testing for SLC16A1 variants provides a definitive diagnosis for unexplained exercise intolerance and hyperlactatemia. It is essential to interpret results in the context of clinical and biochemical findings. I advise patients to use this test as part of a comprehensive metabolic evaluation, not as a standalone diagnosis.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Precautions
- Do not discontinue any prescribed medication (e.g., beta‑blockers, insulin, or metabolic supplements) without explicit instruction from your treating physician.
- Patients on anticoagulant therapy must inform the phlebotomist; an alternative sample (FTA card) may be recommended.
- Children under 1 year require a pediatrician’s clearance and guardian consent as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Exclusion Criteria & Emergency Red Flags
- Do not provide a sample if you have an active severe infection or uncontrolled metabolic crisis — reschedule after stabilization.
- If you experience chest pain, severe muscle breakdown (dark urine), or confusion before sample collection, seek emergency care immediately — do not proceed with the test.
- Children under 1 year require pediatrician clearance and guardian consent as per Federal Decree‑Law No. 4 of 2016.
Patient FAQ & Clinical Guidance
1. How does the SLC16A1 NGS test differ from a routine blood lactate measurement?
Our NGS test directly identifies the underlying genetic defect in the lactate transporter gene with 99.9% analytical sensitivity, providing a definitive molecular diagnosis rather than a transient biochemical snapshot.
2. What sample types are accepted, and does home collection ensure sample stability?
We accept whole blood, extracted DNA, or a single drop of blood on an FTA card — all samples are transported in our ISO‑certified cold chain at 2–8 °C, guaranteeing DNA integrity for up to 14 days.
3. Will I receive clinical interpretation of my results, or just raw data?
Every report includes a board‑certified clinical geneticist’s interpretation and a post‑test tele‑consultation to explain the variant’s impact, inheritance risk, and actionable next steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: Licensed by DHA/MOHAP (Facility License 1143). All sample logistics comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SLC16A1 Gene Erythrocyte Lactate Transporter Defect Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene coding region, splice sites, and regulatory regions |
| ICD‑10‑CM Code | E74.81 |
| LOINC Code | 92834-7 |
| DHA Facility License & Laboratory Address | DHA License 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians